Autism – Medical Marijuana

Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces

By admin| 2016-06-24T15:01:38+01:00 June 24th, 2016|

Use of dronabinol (delta-9-THC) in autism- A prospective single-case-study with an early infantile autistic child

By admin| 2016-06-24T15:01:01+01:00 June 24th, 2016|

Uncoupling of the endocannabinoid signaling complex in a mouse model of fragile X syndrome

By admin| 2016-06-24T15:00:16+01:00 June 24th, 2016|

Species differences in cannabinoid receptor 2 (CNR2 gene)- identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

By admin| 2016-06-24T14:58:04+01:00 June 24th, 2016|

Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression

By admin| 2016-06-24T14:57:04+01:00 June 24th, 2016|

Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion- Effects of Chronic Pubertal Cannabinoid Treatment

By admin| 2016-06-24T14:54:44+01:00 June 24th, 2016|

Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders

By admin| 2016-06-24T14:54:06+01:00 June 24th, 2016|

Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders

By admin| 2016-06-24T14:53:31+01:00 June 24th, 2016|

Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling

By admin| 2016-06-24T14:52:44+01:00 June 24th, 2016|

Alterations in the endocannabinoid system in the rat valproic acid model of autism

By admin| 2016-06-24T14:52:02+01:00 June 24th, 2016|